Senior cosmetic surgeon and clinical scientist Dr. Debraj Shome has called on policymakers to address what he describes as a long-standing inconsistency in India’s healthcare taxation framework, particularly concerning chemotherapy-induced hair loss among cancer patients.
Dr. Shome, who also serves as a mentor at the QR678® Research Platform, argued that while cancer treatments and their surgical reconstruction are appropriately classified as medically essential and benefit from GST rationalization, therapies addressing treatment-induced hair loss continue to be taxed as elective cosmetic services. He said this distinction is difficult to justify when hair loss is a direct and unavoidable consequence of life-saving cancer therapies.
“As India strengthens its commitment to equitable, patient-centric healthcare, the Union Budget offers a critical opportunity to correct this disparity,” Dr. Shome said. He noted that treatments such as chemotherapy, radiation therapy, mastectomy, ovarian surgery, and post-cancer breast reconstruction are rightly recognized as essential medical care, yet the psychological and physical aftereffects of these interventions are often overlooked in tax policy.
For women undergoing treatment for breast and ovarian cancers, Dr. Shome emphasized that hair loss is not a matter of personal choice or cosmetic preference. Instead, it is a treatment-induced condition that can profoundly affect mental health, self-identity, social engagement, and, in some cases, a patient’s willingness to continue therapy.
International oncology research supports this concern, linking untreated post-chemotherapy alopecia to increased rates of depression, anxiety, social withdrawal, and reduced adherence to prescribed cancer treatments. According to Dr. Shome, failing to address these outcomes undermines the broader goal of comprehensive cancer care.
He further stated that rationalizing GST on medically indicated hair restoration and reconstructive scalp treatments would ease the financial burden on cancer survivors and bring India’s healthcare taxation policies closer to global best practices. Such practices increasingly recognize recovery as encompassing both physical healing and psychological rehabilitation.
Dr. Shome concluded that revisiting the tax classification of these treatments would signal a more mature and compassionate healthcare system—one that values dignity, quality of life, and long-term survivorship outcomes, particularly for women navigating life after cancer.
